Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myelomaLukas John, Nicola Giesen, Michael Hundemer et al.|Frontiers in Oncology|2023Cited by 5
Impact of Novel Therapies on CD4-T-Cell-Numbers and Infectious Complications in Patients with Relapsed/Refractory Multiple MyelomaLukas John, Nicola Giesen, Kaya Miah et al.|Blood|2020Cited by 0